×
0.0466403162055336 0.0466403162055336 0.0474308300395257 0.0474308300395257 0.0474308300395257 0.0474308300395257 0.000395256916996109 0.0118577075098814
Stockreport

Syros Presents New Preclinical Data on SY-1365, Its First-in-Class Selective CDK7 Inhibitor, and Discovery of Potential New Drug Targets in Triple Negative Breast Cancer at San Antonio Bre...

SYROS PHARMACEUTICALS (SYRS)  More Company Research Source: Business Wire
Last syros pharmaceuticals earnings: 5/10 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: ir.syros.com
PDF SY-1365 Shows Anti-Tumor Activity Across Broad Panel of Breast Cancer Cell Lines Company Identifies Potential Biomarkers to Predict Response to SY-1365 Analysis of Regulatory Genome of Cancer Stem Cells in Triple Negative Breast Cancer Reveals Potential New Targets for Attacking Relapse and Metastasis CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Syros Pharmaceuticals (NASDAQ: SYRS), a biopharmaceutical company pioneering the discovery and development of medicines to control the expression of disease-driving genes, today announced that new preclinical data on SY-1365, its first-in-class selective cyclin-dependent kinase 7 (CDK7) inhibitor currently in a Phase 1 clinical trial in advanced solid tumors, demonstrate anti-tumor activity across a broad panel of breast cancer cell lines and point to potential biomarkers predictive of response. The Company also announced its identification of key gen [Read more]

IMPACT SNAPSHOT EVENT TIME: SYRS
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS